Sign in
4

Changes in Ownership

Cullinan Therapeutics, Inc. Filed Acc 0001209191-21-051147

Director sold 2,857 shares at $29.05 ($82,996)

From the SEC's structured data for this filing

Trades in this filing

GADICKE ANSBERT · Director

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2021-08-11 Sale : show line 1 in the form −347 $29.05 $10,080 280,921 D
2021-08-11 Sale : show line 2 in the form −2,510 $29.05 $72,916 7,911,377 I
Open-market sales · 2,857 sh · avg $29.05 · $82,996
Loading xslF345X03/doc4.xml…